nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A5—Sorafenib—thyroid cancer	0.0686	0.301	CbGbCtD
Boceprevir—ABCB1—Sorafenib—thyroid cancer	0.0446	0.196	CbGbCtD
Boceprevir—CYP3A4—Vandetanib—thyroid cancer	0.0443	0.195	CbGbCtD
Boceprevir—ABCB1—Doxorubicin—thyroid cancer	0.0271	0.119	CbGbCtD
Boceprevir—CYP3A4—Sorafenib—thyroid cancer	0.0267	0.117	CbGbCtD
Boceprevir—CTSL—neck—thyroid cancer	0.0177	0.0974	CbGeAlD
Boceprevir—CYP3A4—Doxorubicin—thyroid cancer	0.0162	0.0713	CbGbCtD
Boceprevir—CTSL—saliva-secreting gland—thyroid cancer	0.0138	0.076	CbGeAlD
Boceprevir—CTSV—trachea—thyroid cancer	0.0131	0.0717	CbGeAlD
Boceprevir—CTSS—neck—thyroid cancer	0.0117	0.0643	CbGeAlD
Boceprevir—CTSL—trachea—thyroid cancer	0.0107	0.0586	CbGeAlD
Boceprevir—CTSK—saliva-secreting gland—thyroid cancer	0.0104	0.0572	CbGeAlD
Boceprevir—CTSV—thyroid gland—thyroid cancer	0.0103	0.0568	CbGeAlD
Boceprevir—CTSV—head—thyroid cancer	0.00916	0.0503	CbGeAlD
Boceprevir—CTSS—saliva-secreting gland—thyroid cancer	0.00913	0.0501	CbGeAlD
Boceprevir—CTSL—thyroid gland—thyroid cancer	0.00843	0.0464	CbGeAlD
Boceprevir—CTSK—trachea—thyroid cancer	0.00803	0.0441	CbGeAlD
Boceprevir—CTSL—head—thyroid cancer	0.00748	0.0411	CbGeAlD
Boceprevir—CTSS—trachea—thyroid cancer	0.00704	0.0387	CbGeAlD
Boceprevir—CTSK—thyroid gland—thyroid cancer	0.00636	0.0349	CbGeAlD
Boceprevir—CMA1—lymph node—thyroid cancer	0.00613	0.0337	CbGeAlD
Boceprevir—CTSK—head—thyroid cancer	0.00564	0.031	CbGeAlD
Boceprevir—CTSS—thyroid gland—thyroid cancer	0.00557	0.0306	CbGeAlD
Boceprevir—CTSL—lymph node—thyroid cancer	0.00524	0.0288	CbGeAlD
Boceprevir—CTSS—head—thyroid cancer	0.00494	0.0271	CbGeAlD
Boceprevir—CTSK—lymph node—thyroid cancer	0.00395	0.0217	CbGeAlD
Boceprevir—CTSV—Endochondral Ossification—PTCH1—thyroid cancer	0.00379	0.0525	CbGpPWpGaD
Boceprevir—CTSS—lymph node—thyroid cancer	0.00346	0.019	CbGeAlD
Boceprevir—CTSV—Extracellular matrix organization—LAMA2—thyroid cancer	0.00173	0.024	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—LAMA2—thyroid cancer	0.00173	0.024	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—LAMA2—thyroid cancer	0.00161	0.0223	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—CDK1—thyroid cancer	0.0016	0.0222	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—CDK1—thyroid cancer	0.0016	0.0222	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—CDK1—thyroid cancer	0.00149	0.0207	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—LAMA2—thyroid cancer	0.00143	0.0199	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—CDK1—thyroid cancer	0.00133	0.0184	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—RAP1GAP—thyroid cancer	0.00128	0.0178	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—RAP1GAP—thyroid cancer	0.00128	0.0178	CbGpPWpGaD
Boceprevir—ABCB1—trachea—thyroid cancer	0.00124	0.00682	CbGeAlD
Boceprevir—CMA1—Signaling by SCF-KIT—NRG1—thyroid cancer	0.0012	0.0166	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—LAMA2—thyroid cancer	0.00118	0.0164	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—CDK1—thyroid cancer	0.00109	0.0152	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—RAP1GAP—thyroid cancer	0.00106	0.0147	CbGpPWpGaD
Boceprevir—ABCB1—thyroid gland—thyroid cancer	0.000982	0.0054	CbGeAlD
Boceprevir—CTSS—Adaptive Immune System—RAP1GAP—thyroid cancer	0.000875	0.0121	CbGpPWpGaD
Boceprevir—ABCB1—head—thyroid cancer	0.000872	0.00479	CbGeAlD
Boceprevir—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000857	0.0119	CbGpPWpGaD
Boceprevir—CTSV—Immune System—RAP1GAP—thyroid cancer	0.000778	0.0108	CbGpPWpGaD
Boceprevir—CTSL—Immune System—RAP1GAP—thyroid cancer	0.000778	0.0108	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—LGALS3—thyroid cancer	0.000761	0.0105	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—LGALS3—thyroid cancer	0.000761	0.0105	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PRKAR1A—thyroid cancer	0.000755	0.0105	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PRKAR1A—thyroid cancer	0.000755	0.0105	CbGpPWpGaD
Boceprevir—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000727	0.0101	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—AKT1—thyroid cancer	0.000699	0.0097	CbGpPWpGaD
Boceprevir—CTSK—RANKL/RANK Signaling Pathway—AKT1—thyroid cancer	0.000654	0.00907	CbGpPWpGaD
Boceprevir—CTSK—Immune System—RAP1GAP—thyroid cancer	0.000644	0.00894	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—CHST14—thyroid cancer	0.000641	0.00889	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—AKT1—thyroid cancer	0.000636	0.00883	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—LGALS3—thyroid cancer	0.00063	0.00874	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PRKAR1A—thyroid cancer	0.000625	0.00867	CbGpPWpGaD
Boceprevir—ABCB1—lymph node—thyroid cancer	0.00061	0.00335	CbGeAlD
Boceprevir—CMA1—Signaling by SCF-KIT—PTEN—thyroid cancer	0.0006	0.00832	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CALCB—thyroid cancer	0.00058	0.00804	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TRIM33—thyroid cancer	0.00055	0.00762	CbGpPWpGaD
Boceprevir—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000549	0.00761	CbGpPWpGaD
Boceprevir—Urticaria—Sorafenib—thyroid cancer	0.000539	0.00104	CcSEcCtD
Boceprevir—Body temperature increased—Sorafenib—thyroid cancer	0.000537	0.00104	CcSEcCtD
Boceprevir—Abdominal pain—Sorafenib—thyroid cancer	0.000537	0.00104	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—NRAS—thyroid cancer	0.000535	0.00742	CbGpPWpGaD
Boceprevir—CTSS—Immune System—RAP1GAP—thyroid cancer	0.000531	0.00736	CbGpPWpGaD
Boceprevir—Eczema—Doxorubicin—thyroid cancer	0.000526	0.00101	CcSEcCtD
Boceprevir—Eye pain—Doxorubicin—thyroid cancer	0.000523	0.00101	CcSEcCtD
Boceprevir—Lethargy—Epirubicin—thyroid cancer	0.000521	0.001	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—CDK1—thyroid cancer	0.00052	0.00721	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CDK1—thyroid cancer	0.00052	0.00721	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—LGALS3—thyroid cancer	0.000519	0.0072	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PRKAR1A—thyroid cancer	0.000515	0.00714	CbGpPWpGaD
Boceprevir—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000513	0.00711	CbGpPWpGaD
Boceprevir—Pain in extremity—Epirubicin—thyroid cancer	0.00051	0.000985	CcSEcCtD
Boceprevir—Affect lability—Epirubicin—thyroid cancer	0.000502	0.000969	CcSEcCtD
Boceprevir—Migraine—Epirubicin—thyroid cancer	0.000502	0.000969	CcSEcCtD
Boceprevir—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000501	0.000966	CcSEcCtD
Boceprevir—Hypersensitivity—Sorafenib—thyroid cancer	0.0005	0.000965	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—IFNA2—thyroid cancer	0.0005	0.00693	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IFNA2—thyroid cancer	0.0005	0.00693	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000489	0.00678	CbGpPWpGaD
Boceprevir—Asthenia—Sorafenib—thyroid cancer	0.000487	0.00094	CcSEcCtD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000487	0.00675	CbGpPWpGaD
Boceprevir—Mood swings—Epirubicin—thyroid cancer	0.000484	0.000933	CcSEcCtD
Boceprevir—Lethargy—Doxorubicin—thyroid cancer	0.000482	0.00093	CcSEcCtD
Boceprevir—Pruritus—Sorafenib—thyroid cancer	0.00048	0.000926	CcSEcCtD
Boceprevir—Dehydration—Epirubicin—thyroid cancer	0.000475	0.000916	CcSEcCtD
Boceprevir—Pain in extremity—Doxorubicin—thyroid cancer	0.000472	0.000911	CcSEcCtD
Boceprevir—Dry skin—Epirubicin—thyroid cancer	0.000468	0.000903	CcSEcCtD
Boceprevir—Abdominal pain upper—Epirubicin—thyroid cancer	0.000466	0.000899	CcSEcCtD
Boceprevir—Affect lability—Doxorubicin—thyroid cancer	0.000465	0.000897	CcSEcCtD
Boceprevir—Migraine—Doxorubicin—thyroid cancer	0.000465	0.000897	CcSEcCtD
Boceprevir—Hypokalaemia—Epirubicin—thyroid cancer	0.000465	0.000896	CcSEcCtD
Boceprevir—Diarrhoea—Sorafenib—thyroid cancer	0.000464	0.000896	CcSEcCtD
Boceprevir—Breast disorder—Epirubicin—thyroid cancer	0.000461	0.00089	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—KRAS—thyroid cancer	0.00046	0.00639	CbGpPWpGaD
Boceprevir—Nasopharyngitis—Epirubicin—thyroid cancer	0.000456	0.00088	CcSEcCtD
Boceprevir—Gastritis—Epirubicin—thyroid cancer	0.000452	0.000871	CcSEcCtD
Boceprevir—Muscular weakness—Epirubicin—thyroid cancer	0.00045	0.000868	CcSEcCtD
Boceprevir—Dizziness—Sorafenib—thyroid cancer	0.000449	0.000866	CcSEcCtD
Boceprevir—Mood swings—Doxorubicin—thyroid cancer	0.000447	0.000863	CcSEcCtD
Boceprevir—CTSV—Immune System—TPR—thyroid cancer	0.000447	0.00619	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TPR—thyroid cancer	0.000447	0.00619	CbGpPWpGaD
Boceprevir—Abdominal distension—Epirubicin—thyroid cancer	0.000444	0.000857	CcSEcCtD
Boceprevir—CTSV—Immune System—LGALS3—thyroid cancer	0.000443	0.00614	CbGpPWpGaD
Boceprevir—CTSL—Immune System—LGALS3—thyroid cancer	0.000443	0.00614	CbGpPWpGaD
Boceprevir—Dysphagia—Epirubicin—thyroid cancer	0.000441	0.000851	CcSEcCtD
Boceprevir—Influenza—Epirubicin—thyroid cancer	0.000441	0.000851	CcSEcCtD
Boceprevir—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00044	0.0061	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PRKAR1A—thyroid cancer	0.000439	0.00609	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PRKAR1A—thyroid cancer	0.000439	0.00609	CbGpPWpGaD
Boceprevir—Dehydration—Doxorubicin—thyroid cancer	0.000439	0.000847	CcSEcCtD
Boceprevir—Eosinophilia—Epirubicin—thyroid cancer	0.000437	0.000843	CcSEcCtD
Boceprevir—Dry skin—Doxorubicin—thyroid cancer	0.000433	0.000835	CcSEcCtD
Boceprevir—Pancreatitis—Epirubicin—thyroid cancer	0.000433	0.000834	CcSEcCtD
Boceprevir—Vomiting—Sorafenib—thyroid cancer	0.000432	0.000833	CcSEcCtD
Boceprevir—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000431	0.000832	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—CDK1—thyroid cancer	0.000431	0.00597	CbGpPWpGaD
Boceprevir—Hypokalaemia—Doxorubicin—thyroid cancer	0.00043	0.000829	CcSEcCtD
Boceprevir—Rash—Sorafenib—thyroid cancer	0.000428	0.000826	CcSEcCtD
Boceprevir—Dermatitis—Sorafenib—thyroid cancer	0.000428	0.000825	CcSEcCtD
Boceprevir—Breast disorder—Doxorubicin—thyroid cancer	0.000427	0.000823	CcSEcCtD
Boceprevir—Headache—Sorafenib—thyroid cancer	0.000425	0.00082	CcSEcCtD
Boceprevir—Bronchitis—Epirubicin—thyroid cancer	0.000424	0.000818	CcSEcCtD
Boceprevir—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000422	0.000815	CcSEcCtD
Boceprevir—Pancytopenia—Epirubicin—thyroid cancer	0.000419	0.000808	CcSEcCtD
Boceprevir—Gastritis—Doxorubicin—thyroid cancer	0.000418	0.000806	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—NRG1—thyroid cancer	0.000417	0.00579	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NRG1—thyroid cancer	0.000417	0.00579	CbGpPWpGaD
Boceprevir—Muscular weakness—Doxorubicin—thyroid cancer	0.000417	0.000804	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—IFNA2—thyroid cancer	0.000414	0.00574	CbGpPWpGaD
Boceprevir—Neutropenia—Epirubicin—thyroid cancer	0.000413	0.000796	CcSEcCtD
Boceprevir—Dysuria—Epirubicin—thyroid cancer	0.000413	0.000796	CcSEcCtD
Boceprevir—Abdominal distension—Doxorubicin—thyroid cancer	0.000411	0.000793	CcSEcCtD
Boceprevir—Influenza—Doxorubicin—thyroid cancer	0.000408	0.000787	CcSEcCtD
Boceprevir—Dysphagia—Doxorubicin—thyroid cancer	0.000408	0.000787	CcSEcCtD
Boceprevir—Pollakiuria—Epirubicin—thyroid cancer	0.000408	0.000786	CcSEcCtD
Boceprevir—Eosinophilia—Doxorubicin—thyroid cancer	0.000404	0.00078	CcSEcCtD
Boceprevir—Nausea—Sorafenib—thyroid cancer	0.000403	0.000778	CcSEcCtD
Boceprevir—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000403	0.000777	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—NRG1—thyroid cancer	0.000401	0.00556	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—NRG1—thyroid cancer	0.000401	0.00556	CbGpPWpGaD
Boceprevir—Pancreatitis—Doxorubicin—thyroid cancer	0.0004	0.000772	CcSEcCtD
Boceprevir—Weight decreased—Epirubicin—thyroid cancer	0.000399	0.00077	CcSEcCtD
Boceprevir—Hyperglycaemia—Epirubicin—thyroid cancer	0.000398	0.000768	CcSEcCtD
Boceprevir—Pneumonia—Epirubicin—thyroid cancer	0.000396	0.000763	CcSEcCtD
Boceprevir—Infestation—Epirubicin—thyroid cancer	0.000393	0.000759	CcSEcCtD
Boceprevir—Infestation NOS—Epirubicin—thyroid cancer	0.000393	0.000759	CcSEcCtD
Boceprevir—Bronchitis—Doxorubicin—thyroid cancer	0.000393	0.000757	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—HRAS—thyroid cancer	0.000391	0.00543	CbGpPWpGaD
Boceprevir—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00039	0.000752	CcSEcCtD
Boceprevir—Pancytopenia—Doxorubicin—thyroid cancer	0.000388	0.000748	CcSEcCtD
Boceprevir—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000386	0.000744	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000384	0.00532	CbGpPWpGaD
Boceprevir—Stomatitis—Epirubicin—thyroid cancer	0.000383	0.00074	CcSEcCtD
Boceprevir—Urinary tract infection—Epirubicin—thyroid cancer	0.000382	0.000738	CcSEcCtD
Boceprevir—Conjunctivitis—Epirubicin—thyroid cancer	0.000382	0.000738	CcSEcCtD
Boceprevir—Neutropenia—Doxorubicin—thyroid cancer	0.000382	0.000736	CcSEcCtD
Boceprevir—Dysuria—Doxorubicin—thyroid cancer	0.000382	0.000736	CcSEcCtD
Boceprevir—Pollakiuria—Doxorubicin—thyroid cancer	0.000377	0.000727	CcSEcCtD
Boceprevir—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000373	0.000719	CcSEcCtD
Boceprevir—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000372	0.000718	CcSEcCtD
Boceprevir—Epistaxis—Epirubicin—thyroid cancer	0.000371	0.000716	CcSEcCtD
Boceprevir—CTSK—Immune System—TPR—thyroid cancer	0.00037	0.00513	CbGpPWpGaD
Boceprevir—Weight decreased—Doxorubicin—thyroid cancer	0.000369	0.000712	CcSEcCtD
Boceprevir—Sinusitis—Epirubicin—thyroid cancer	0.000369	0.000712	CcSEcCtD
Boceprevir—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000368	0.00071	CcSEcCtD
Boceprevir—CTSK—Immune System—LGALS3—thyroid cancer	0.000367	0.00509	CbGpPWpGaD
Boceprevir—Agranulocytosis—Epirubicin—thyroid cancer	0.000367	0.000708	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—TCF7L1—thyroid cancer	0.000367	0.00509	CbGpPWpGaD
Boceprevir—Pneumonia—Doxorubicin—thyroid cancer	0.000366	0.000706	CcSEcCtD
Boceprevir—CTSK—Immune System—PRKAR1A—thyroid cancer	0.000364	0.00505	CbGpPWpGaD
Boceprevir—Infestation NOS—Doxorubicin—thyroid cancer	0.000364	0.000702	CcSEcCtD
Boceprevir—Infestation—Doxorubicin—thyroid cancer	0.000364	0.000702	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000361	0.000696	CcSEcCtD
Boceprevir—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000357	0.000688	CcSEcCtD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000356	0.00494	CbGpPWpGaD
Boceprevir—Stomatitis—Doxorubicin—thyroid cancer	0.000355	0.000684	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CDK1—thyroid cancer	0.000355	0.00492	CbGpPWpGaD
Boceprevir—Rhinitis—Epirubicin—thyroid cancer	0.000354	0.000683	CcSEcCtD
Boceprevir—Conjunctivitis—Doxorubicin—thyroid cancer	0.000354	0.000682	CcSEcCtD
Boceprevir—Urinary tract infection—Doxorubicin—thyroid cancer	0.000354	0.000682	CcSEcCtD
Boceprevir—Hypoaesthesia—Epirubicin—thyroid cancer	0.000351	0.000678	CcSEcCtD
Boceprevir—Pharyngitis—Epirubicin—thyroid cancer	0.00035	0.000676	CcSEcCtD
Boceprevir—Urinary tract disorder—Epirubicin—thyroid cancer	0.000349	0.000673	CcSEcCtD
Boceprevir—Oedema peripheral—Epirubicin—thyroid cancer	0.000348	0.000671	CcSEcCtD
Boceprevir—Connective tissue disorder—Epirubicin—thyroid cancer	0.000347	0.000669	CcSEcCtD
Boceprevir—Urethral disorder—Epirubicin—thyroid cancer	0.000346	0.000668	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—NRG1—thyroid cancer	0.000346	0.00479	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—AKT1—thyroid cancer	0.000346	0.00479	CbGpPWpGaD
Boceprevir—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000344	0.000664	CcSEcCtD
Boceprevir—Epistaxis—Doxorubicin—thyroid cancer	0.000343	0.000662	CcSEcCtD
Boceprevir—Sinusitis—Doxorubicin—thyroid cancer	0.000341	0.000659	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—IFNA2—thyroid cancer	0.000341	0.00473	CbGpPWpGaD
Boceprevir—Visual impairment—Epirubicin—thyroid cancer	0.00034	0.000656	CcSEcCtD
Boceprevir—Agranulocytosis—Doxorubicin—thyroid cancer	0.00034	0.000655	CcSEcCtD
Boceprevir—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000338	0.00469	CbGpPWpGaD
Boceprevir—Erythema multiforme—Epirubicin—thyroid cancer	0.000334	0.000644	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—NRG1—thyroid cancer	0.000332	0.0046	CbGpPWpGaD
Boceprevir—Eye disorder—Epirubicin—thyroid cancer	0.00033	0.000637	CcSEcCtD
Boceprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.00033	0.00458	CbGpPWpGaD
Boceprevir—Tinnitus—Epirubicin—thyroid cancer	0.000329	0.000635	CcSEcCtD
Boceprevir—Cardiac disorder—Epirubicin—thyroid cancer	0.000328	0.000632	CcSEcCtD
Boceprevir—Flushing—Epirubicin—thyroid cancer	0.000328	0.000632	CcSEcCtD
Boceprevir—Rhinitis—Doxorubicin—thyroid cancer	0.000328	0.000632	CcSEcCtD
Boceprevir—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000325	0.000627	CcSEcCtD
Boceprevir—Pharyngitis—Doxorubicin—thyroid cancer	0.000324	0.000626	CcSEcCtD
Boceprevir—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000323	0.000622	CcSEcCtD
Boceprevir—Oedema peripheral—Doxorubicin—thyroid cancer	0.000322	0.000621	CcSEcCtD
Boceprevir—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000321	0.000619	CcSEcCtD
Boceprevir—Angiopathy—Epirubicin—thyroid cancer	0.00032	0.000618	CcSEcCtD
Boceprevir—Urethral disorder—Doxorubicin—thyroid cancer	0.00032	0.000618	CcSEcCtD
Boceprevir—Immune system disorder—Epirubicin—thyroid cancer	0.000319	0.000615	CcSEcCtD
Boceprevir—Mediastinal disorder—Epirubicin—thyroid cancer	0.000318	0.000614	CcSEcCtD
Boceprevir—Chills—Epirubicin—thyroid cancer	0.000317	0.000611	CcSEcCtD
Boceprevir—Arrhythmia—Epirubicin—thyroid cancer	0.000315	0.000608	CcSEcCtD
Boceprevir—Visual impairment—Doxorubicin—thyroid cancer	0.000315	0.000607	CcSEcCtD
Boceprevir—Alopecia—Epirubicin—thyroid cancer	0.000312	0.000602	CcSEcCtD
Boceprevir—Mental disorder—Epirubicin—thyroid cancer	0.000309	0.000597	CcSEcCtD
Boceprevir—Erythema multiforme—Doxorubicin—thyroid cancer	0.000309	0.000596	CcSEcCtD
Boceprevir—Malnutrition—Epirubicin—thyroid cancer	0.000307	0.000593	CcSEcCtD
Boceprevir—Erythema—Epirubicin—thyroid cancer	0.000307	0.000593	CcSEcCtD
Boceprevir—Eye disorder—Doxorubicin—thyroid cancer	0.000305	0.000589	CcSEcCtD
Boceprevir—CTSS—Immune System—TPR—thyroid cancer	0.000305	0.00423	CbGpPWpGaD
Boceprevir—Tinnitus—Doxorubicin—thyroid cancer	0.000305	0.000588	CcSEcCtD
Boceprevir—Flushing—Doxorubicin—thyroid cancer	0.000303	0.000585	CcSEcCtD
Boceprevir—Cardiac disorder—Doxorubicin—thyroid cancer	0.000303	0.000585	CcSEcCtD
Boceprevir—Flatulence—Epirubicin—thyroid cancer	0.000303	0.000584	CcSEcCtD
Boceprevir—CTSL—Immune System—CDK1—thyroid cancer	0.000303	0.0042	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CDK1—thyroid cancer	0.000303	0.0042	CbGpPWpGaD
Boceprevir—CTSS—Immune System—LGALS3—thyroid cancer	0.000302	0.00419	CbGpPWpGaD
Boceprevir—Dysgeusia—Epirubicin—thyroid cancer	0.000301	0.000581	CcSEcCtD
Boceprevir—CTSS—Immune System—PRKAR1A—thyroid cancer	0.0003	0.00416	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000298	0.00413	CbGpPWpGaD
Boceprevir—Back pain—Epirubicin—thyroid cancer	0.000297	0.000574	CcSEcCtD
Boceprevir—Angiopathy—Doxorubicin—thyroid cancer	0.000296	0.000572	CcSEcCtD
Boceprevir—Muscle spasms—Epirubicin—thyroid cancer	0.000296	0.00057	CcSEcCtD
Boceprevir—Immune system disorder—Doxorubicin—thyroid cancer	0.000295	0.000569	CcSEcCtD
Boceprevir—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000294	0.000568	CcSEcCtD
Boceprevir—Chills—Doxorubicin—thyroid cancer	0.000293	0.000566	CcSEcCtD
Boceprevir—Arrhythmia—Doxorubicin—thyroid cancer	0.000292	0.000563	CcSEcCtD
Boceprevir—CTSL—Immune System—IFNA2—thyroid cancer	0.000291	0.00404	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IFNA2—thyroid cancer	0.000291	0.00404	CbGpPWpGaD
Boceprevir—Vision blurred—Epirubicin—thyroid cancer	0.00029	0.000559	CcSEcCtD
Boceprevir—Alopecia—Doxorubicin—thyroid cancer	0.000289	0.000557	CcSEcCtD
Boceprevir—Mental disorder—Doxorubicin—thyroid cancer	0.000286	0.000552	CcSEcCtD
Boceprevir—Ill-defined disorder—Epirubicin—thyroid cancer	0.000285	0.00055	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—NRG1—thyroid cancer	0.000285	0.00395	CbGpPWpGaD
Boceprevir—Malnutrition—Doxorubicin—thyroid cancer	0.000284	0.000549	CcSEcCtD
Boceprevir—Erythema—Doxorubicin—thyroid cancer	0.000284	0.000549	CcSEcCtD
Boceprevir—Anaemia—Epirubicin—thyroid cancer	0.000284	0.000548	CcSEcCtD
Boceprevir—Agitation—Epirubicin—thyroid cancer	0.000282	0.000545	CcSEcCtD
Boceprevir—Flatulence—Doxorubicin—thyroid cancer	0.00028	0.000541	CcSEcCtD
Boceprevir—Dysgeusia—Doxorubicin—thyroid cancer	0.000279	0.000537	CcSEcCtD
Boceprevir—Malaise—Epirubicin—thyroid cancer	0.000277	0.000535	CcSEcCtD
Boceprevir—Vertigo—Epirubicin—thyroid cancer	0.000276	0.000533	CcSEcCtD
Boceprevir—Syncope—Epirubicin—thyroid cancer	0.000276	0.000532	CcSEcCtD
Boceprevir—Leukopenia—Epirubicin—thyroid cancer	0.000275	0.000531	CcSEcCtD
Boceprevir—Back pain—Doxorubicin—thyroid cancer	0.000275	0.000531	CcSEcCtD
Boceprevir—Muscle spasms—Doxorubicin—thyroid cancer	0.000273	0.000527	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—NRG1—thyroid cancer	0.000273	0.00379	CbGpPWpGaD
Boceprevir—Palpitations—Epirubicin—thyroid cancer	0.000272	0.000524	CcSEcCtD
Boceprevir—Loss of consciousness—Epirubicin—thyroid cancer	0.00027	0.000521	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—TSHR—thyroid cancer	0.000268	0.00372	CbGpPWpGaD
Boceprevir—Cough—Epirubicin—thyroid cancer	0.000268	0.000517	CcSEcCtD
Boceprevir—Vision blurred—Doxorubicin—thyroid cancer	0.000268	0.000517	CcSEcCtD
Boceprevir—Hypertension—Epirubicin—thyroid cancer	0.000265	0.000512	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000264	0.00366	CbGpPWpGaD
Boceprevir—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000264	0.000509	CcSEcCtD
Boceprevir—Anaemia—Doxorubicin—thyroid cancer	0.000263	0.000507	CcSEcCtD
Boceprevir—Arthralgia—Epirubicin—thyroid cancer	0.000262	0.000505	CcSEcCtD
Boceprevir—Myalgia—Epirubicin—thyroid cancer	0.000262	0.000505	CcSEcCtD
Boceprevir—Chest pain—Epirubicin—thyroid cancer	0.000262	0.000505	CcSEcCtD
Boceprevir—Agitation—Doxorubicin—thyroid cancer	0.000261	0.000504	CcSEcCtD
Boceprevir—Anxiety—Epirubicin—thyroid cancer	0.000261	0.000503	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00026	0.000501	CcSEcCtD
Boceprevir—Discomfort—Epirubicin—thyroid cancer	0.000259	0.000499	CcSEcCtD
Boceprevir—Malaise—Doxorubicin—thyroid cancer	0.000256	0.000495	CcSEcCtD
Boceprevir—Dry mouth—Epirubicin—thyroid cancer	0.000256	0.000494	CcSEcCtD
Boceprevir—Vertigo—Doxorubicin—thyroid cancer	0.000256	0.000493	CcSEcCtD
Boceprevir—Syncope—Doxorubicin—thyroid cancer	0.000255	0.000492	CcSEcCtD
Boceprevir—Leukopenia—Doxorubicin—thyroid cancer	0.000255	0.000491	CcSEcCtD
Boceprevir—Confusional state—Epirubicin—thyroid cancer	0.000253	0.000488	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—MEN1—thyroid cancer	0.000252	0.0035	CbGpPWpGaD
Boceprevir—Palpitations—Doxorubicin—thyroid cancer	0.000251	0.000485	CcSEcCtD
Boceprevir—CTSK—Immune System—CDK1—thyroid cancer	0.000251	0.00348	CbGpPWpGaD
Boceprevir—Loss of consciousness—Doxorubicin—thyroid cancer	0.00025	0.000482	CcSEcCtD
Boceprevir—Infection—Epirubicin—thyroid cancer	0.000249	0.000481	CcSEcCtD
Boceprevir—Cough—Doxorubicin—thyroid cancer	0.000248	0.000479	CcSEcCtD
Boceprevir—Shock—Epirubicin—thyroid cancer	0.000247	0.000476	CcSEcCtD
Boceprevir—Nervous system disorder—Epirubicin—thyroid cancer	0.000246	0.000475	CcSEcCtD
Boceprevir—Thrombocytopenia—Epirubicin—thyroid cancer	0.000246	0.000474	CcSEcCtD
Boceprevir—Hypertension—Doxorubicin—thyroid cancer	0.000246	0.000474	CcSEcCtD
Boceprevir—Tachycardia—Epirubicin—thyroid cancer	0.000245	0.000472	CcSEcCtD
Boceprevir—Skin disorder—Epirubicin—thyroid cancer	0.000244	0.00047	CcSEcCtD
Boceprevir—CTSV—Immune System—NRG1—thyroid cancer	0.000243	0.00337	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NRG1—thyroid cancer	0.000243	0.00337	CbGpPWpGaD
Boceprevir—Hyperhidrosis—Epirubicin—thyroid cancer	0.000243	0.000468	CcSEcCtD
Boceprevir—Myalgia—Doxorubicin—thyroid cancer	0.000242	0.000467	CcSEcCtD
Boceprevir—Chest pain—Doxorubicin—thyroid cancer	0.000242	0.000467	CcSEcCtD
Boceprevir—Arthralgia—Doxorubicin—thyroid cancer	0.000242	0.000467	CcSEcCtD
Boceprevir—Anxiety—Doxorubicin—thyroid cancer	0.000241	0.000465	CcSEcCtD
Boceprevir—CTSK—Immune System—IFNA2—thyroid cancer	0.000241	0.00335	CbGpPWpGaD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00024	0.000464	CcSEcCtD
Boceprevir—Discomfort—Doxorubicin—thyroid cancer	0.000239	0.000461	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000239	0.00331	CbGpPWpGaD
Boceprevir—Dry mouth—Doxorubicin—thyroid cancer	0.000237	0.000457	CcSEcCtD
Boceprevir—Hypotension—Epirubicin—thyroid cancer	0.000234	0.000452	CcSEcCtD
Boceprevir—Confusional state—Doxorubicin—thyroid cancer	0.000234	0.000451	CcSEcCtD
Boceprevir—Infection—Doxorubicin—thyroid cancer	0.000231	0.000445	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000229	0.000441	CcSEcCtD
Boceprevir—Shock—Doxorubicin—thyroid cancer	0.000228	0.000441	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PTCH1—thyroid cancer	0.000228	0.00317	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000228	0.00317	CbGpPWpGaD
Boceprevir—Nervous system disorder—Doxorubicin—thyroid cancer	0.000228	0.000439	CcSEcCtD
Boceprevir—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000227	0.000438	CcSEcCtD
Boceprevir—Insomnia—Epirubicin—thyroid cancer	0.000227	0.000438	CcSEcCtD
Boceprevir—Tachycardia—Doxorubicin—thyroid cancer	0.000227	0.000437	CcSEcCtD
Boceprevir—Skin disorder—Doxorubicin—thyroid cancer	0.000225	0.000435	CcSEcCtD
Boceprevir—Paraesthesia—Epirubicin—thyroid cancer	0.000225	0.000435	CcSEcCtD
Boceprevir—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000224	0.000433	CcSEcCtD
Boceprevir—Dyspnoea—Epirubicin—thyroid cancer	0.000224	0.000431	CcSEcCtD
Boceprevir—Dyspepsia—Epirubicin—thyroid cancer	0.000221	0.000426	CcSEcCtD
Boceprevir—Decreased appetite—Epirubicin—thyroid cancer	0.000218	0.000421	CcSEcCtD
Boceprevir—Hypotension—Doxorubicin—thyroid cancer	0.000217	0.000418	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000217	0.000418	CcSEcCtD
Boceprevir—Fatigue—Epirubicin—thyroid cancer	0.000216	0.000417	CcSEcCtD
Boceprevir—Constipation—Epirubicin—thyroid cancer	0.000215	0.000414	CcSEcCtD
Boceprevir—Pain—Epirubicin—thyroid cancer	0.000215	0.000414	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000211	0.000408	CcSEcCtD
Boceprevir—Insomnia—Doxorubicin—thyroid cancer	0.00021	0.000405	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—PTEN—thyroid cancer	0.000209	0.0029	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PTEN—thyroid cancer	0.000209	0.0029	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SST—thyroid cancer	0.000209	0.0029	CbGpPWpGaD
Boceprevir—Paraesthesia—Doxorubicin—thyroid cancer	0.000208	0.000402	CcSEcCtD
Boceprevir—Dyspnoea—Doxorubicin—thyroid cancer	0.000207	0.000399	CcSEcCtD
Boceprevir—Feeling abnormal—Epirubicin—thyroid cancer	0.000207	0.000399	CcSEcCtD
Boceprevir—CTSS—Immune System—CDK1—thyroid cancer	0.000207	0.00286	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000205	0.000396	CcSEcCtD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000204	0.00283	CbGpPWpGaD
Boceprevir—Dyspepsia—Doxorubicin—thyroid cancer	0.000204	0.000394	CcSEcCtD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000203	0.00282	CbGpPWpGaD
Boceprevir—Decreased appetite—Doxorubicin—thyroid cancer	0.000202	0.000389	CcSEcCtD
Boceprevir—CTSK—Immune System—NRG1—thyroid cancer	0.000201	0.00279	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CALCA—thyroid cancer	0.000201	0.00279	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PTEN—thyroid cancer	0.000201	0.00278	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—PTEN—thyroid cancer	0.000201	0.00278	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.0002	0.000387	CcSEcCtD
Boceprevir—Fatigue—Doxorubicin—thyroid cancer	0.0002	0.000386	CcSEcCtD
Boceprevir—Urticaria—Epirubicin—thyroid cancer	0.000199	0.000384	CcSEcCtD
Boceprevir—CTSS—Immune System—IFNA2—thyroid cancer	0.000199	0.00275	CbGpPWpGaD
Boceprevir—Pain—Doxorubicin—thyroid cancer	0.000199	0.000383	CcSEcCtD
Boceprevir—Constipation—Doxorubicin—thyroid cancer	0.000199	0.000383	CcSEcCtD
Boceprevir—Abdominal pain—Epirubicin—thyroid cancer	0.000198	0.000383	CcSEcCtD
Boceprevir—Body temperature increased—Epirubicin—thyroid cancer	0.000198	0.000383	CcSEcCtD
Boceprevir—Feeling abnormal—Doxorubicin—thyroid cancer	0.000191	0.000369	CcSEcCtD
Boceprevir—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00019	0.000366	CcSEcCtD
Boceprevir—CYP3A5—Biological oxidations—RXRA—thyroid cancer	0.000189	0.00263	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NRAS—thyroid cancer	0.000186	0.00259	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—NRAS—thyroid cancer	0.000186	0.00259	CbGpPWpGaD
Boceprevir—Hypersensitivity—Epirubicin—thyroid cancer	0.000185	0.000357	CcSEcCtD
Boceprevir—Urticaria—Doxorubicin—thyroid cancer	0.000184	0.000356	CcSEcCtD
Boceprevir—Abdominal pain—Doxorubicin—thyroid cancer	0.000183	0.000354	CcSEcCtD
Boceprevir—Body temperature increased—Doxorubicin—thyroid cancer	0.000183	0.000354	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CDK1—thyroid cancer	0.000182	0.00252	CbGpPWpGaD
Boceprevir—Asthenia—Epirubicin—thyroid cancer	0.00018	0.000347	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—NRAS—thyroid cancer	0.000179	0.00248	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—NRAS—thyroid cancer	0.000179	0.00248	CbGpPWpGaD
Boceprevir—Pruritus—Epirubicin—thyroid cancer	0.000177	0.000342	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—PTEN—thyroid cancer	0.000173	0.0024	CbGpPWpGaD
Boceprevir—Diarrhoea—Epirubicin—thyroid cancer	0.000172	0.000331	CcSEcCtD
Boceprevir—Hypersensitivity—Doxorubicin—thyroid cancer	0.000171	0.00033	CcSEcCtD
Boceprevir—Asthenia—Doxorubicin—thyroid cancer	0.000167	0.000321	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—PTEN—thyroid cancer	0.000166	0.00231	CbGpPWpGaD
Boceprevir—Dizziness—Epirubicin—thyroid cancer	0.000166	0.00032	CcSEcCtD
Boceprevir—CTSS—Immune System—NRG1—thyroid cancer	0.000166	0.0023	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000166	0.0023	CbGpPWpGaD
Boceprevir—Pruritus—Doxorubicin—thyroid cancer	0.000164	0.000317	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—KRAS—thyroid cancer	0.00016	0.00223	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—KRAS—thyroid cancer	0.00016	0.00223	CbGpPWpGaD
Boceprevir—Vomiting—Epirubicin—thyroid cancer	0.00016	0.000308	CcSEcCtD
Boceprevir—Diarrhoea—Doxorubicin—thyroid cancer	0.000159	0.000306	CcSEcCtD
Boceprevir—Rash—Epirubicin—thyroid cancer	0.000158	0.000305	CcSEcCtD
Boceprevir—Dermatitis—Epirubicin—thyroid cancer	0.000158	0.000305	CcSEcCtD
Boceprevir—Headache—Epirubicin—thyroid cancer	0.000157	0.000303	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—NRAS—thyroid cancer	0.000154	0.00214	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—KRAS—thyroid cancer	0.000154	0.00214	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—KRAS—thyroid cancer	0.000154	0.00214	CbGpPWpGaD
Boceprevir—Dizziness—Doxorubicin—thyroid cancer	0.000153	0.000296	CcSEcCtD
Boceprevir—Nausea—Epirubicin—thyroid cancer	0.000149	0.000287	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—NRAS—thyroid cancer	0.000148	0.00206	CbGpPWpGaD
Boceprevir—Vomiting—Doxorubicin—thyroid cancer	0.000148	0.000285	CcSEcCtD
Boceprevir—Rash—Doxorubicin—thyroid cancer	0.000146	0.000282	CcSEcCtD
Boceprevir—Dermatitis—Doxorubicin—thyroid cancer	0.000146	0.000282	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—NRG1—thyroid cancer	0.000146	0.00203	CbGpPWpGaD
Boceprevir—Headache—Doxorubicin—thyroid cancer	0.000145	0.000281	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—PTEN—thyroid cancer	0.000143	0.00198	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MINPP1—thyroid cancer	0.000139	0.00193	CbGpPWpGaD
Boceprevir—Nausea—Doxorubicin—thyroid cancer	0.000138	0.000266	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—PTEN—thyroid cancer	0.000137	0.0019	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HRAS—thyroid cancer	0.000136	0.00189	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—HRAS—thyroid cancer	0.000136	0.00189	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—KRAS—thyroid cancer	0.000133	0.00184	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000131	0.00182	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TERT—thyroid cancer	0.000131	0.00182	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HRAS—thyroid cancer	0.000131	0.00182	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HRAS—thyroid cancer	0.000131	0.00182	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—KRAS—thyroid cancer	0.000128	0.00177	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—NRAS—thyroid cancer	0.000127	0.00176	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HIF1A—thyroid cancer	0.000125	0.00174	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—NRAS—thyroid cancer	0.000122	0.00169	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PTEN—thyroid cancer	0.000122	0.00169	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PTEN—thyroid cancer	0.000122	0.00169	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—AKT1—thyroid cancer	0.00012	0.00167	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—AKT1—thyroid cancer	0.00012	0.00167	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NDUFA13—thyroid cancer	0.000118	0.00164	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—AKT1—thyroid cancer	0.000116	0.0016	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—AKT1—thyroid cancer	0.000116	0.0016	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—HRAS—thyroid cancer	0.000113	0.00157	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CHST14—thyroid cancer	0.000111	0.00154	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—KRAS—thyroid cancer	0.000109	0.00152	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NRAS—thyroid cancer	0.000109	0.00151	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NRAS—thyroid cancer	0.000109	0.00151	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HRAS—thyroid cancer	0.000109	0.0015	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KRAS—thyroid cancer	0.000105	0.00146	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MINPP1—thyroid cancer	0.000105	0.00146	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—BRAF—thyroid cancer	0.000104	0.00144	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PTEN—thyroid cancer	0.000101	0.0014	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—AKT1—thyroid cancer	9.98e-05	0.00138	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AKT1—thyroid cancer	9.58e-05	0.00133	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KRAS—thyroid cancer	9.34e-05	0.0013	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KRAS—thyroid cancer	9.34e-05	0.0013	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HRAS—thyroid cancer	9.31e-05	0.00129	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NRAS—thyroid cancer	9e-05	0.00125	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HPGD—thyroid cancer	8.96e-05	0.00124	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HRAS—thyroid cancer	8.94e-05	0.00124	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NDUFA13—thyroid cancer	8.92e-05	0.00124	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—RXRA—thyroid cancer	8.8e-05	0.00122	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CHST14—thyroid cancer	8.39e-05	0.00116	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTEN—thyroid cancer	8.3e-05	0.00115	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	8.29e-05	0.00115	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	8.29e-05	0.00115	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT1—thyroid cancer	8.22e-05	0.00114	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.16e-05	0.00113	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HRAS—thyroid cancer	7.94e-05	0.0011	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HRAS—thyroid cancer	7.94e-05	0.0011	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—thyroid cancer	7.89e-05	0.00109	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KRAS—thyroid cancer	7.74e-05	0.00107	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	7.67e-05	0.00106	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCND1—thyroid cancer	7.58e-05	0.00105	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NRAS—thyroid cancer	7.41e-05	0.00103	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTEN—thyroid cancer	7.31e-05	0.00101	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—thyroid cancer	7.01e-05	0.000973	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—thyroid cancer	7.01e-05	0.000973	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HPGD—thyroid cancer	6.76e-05	0.000938	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HRAS—thyroid cancer	6.58e-05	0.000913	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NRAS—thyroid cancer	6.53e-05	0.000905	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	6.53e-05	0.000905	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MINPP1—thyroid cancer	6.47e-05	0.000897	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KRAS—thyroid cancer	6.38e-05	0.000884	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.21e-05	0.000861	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	5.9e-05	0.000818	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—thyroid cancer	5.81e-05	0.000806	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	5.69e-05	0.000789	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—thyroid cancer	5.62e-05	0.000779	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NDUFA13—thyroid cancer	5.5e-05	0.000763	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—thyroid cancer	5.42e-05	0.000752	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.22e-05	0.000723	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CHST14—thyroid cancer	5.17e-05	0.000717	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TPR—thyroid cancer	5.15e-05	0.000714	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	5.06e-05	0.000702	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—thyroid cancer	4.99e-05	0.000692	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—thyroid cancer	4.79e-05	0.000664	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—thyroid cancer	4.77e-05	0.000662	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	4.37e-05	0.000606	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—thyroid cancer	4.22e-05	0.000585	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HPGD—thyroid cancer	4.17e-05	0.000578	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TPR—thyroid cancer	3.88e-05	0.000539	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.88e-05	0.000539	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC5A5—thyroid cancer	3.85e-05	0.000534	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PRKAR1A—thyroid cancer	3.82e-05	0.00053	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	3.28e-05	0.000455	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—RXRA—thyroid cancer	3.24e-05	0.000449	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC5A5—thyroid cancer	2.91e-05	0.000403	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—RXRA—thyroid cancer	2.44e-05	0.000339	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TPR—thyroid cancer	2.39e-05	0.000332	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.35e-05	0.000327	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARG—thyroid cancer	2.04e-05	0.000284	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.79e-05	0.000248	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.61e-05	0.000223	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARG—thyroid cancer	1.54e-05	0.000214	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—RXRA—thyroid cancer	1.51e-05	0.000209	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTEN—thyroid cancer	1.4e-05	0.000195	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—thyroid cancer	1.21e-05	0.000168	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTEN—thyroid cancer	1.06e-05	0.000147	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARG—thyroid cancer	9.5e-06	0.000132	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—thyroid cancer	8.08e-06	0.000112	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—thyroid cancer	7.48e-06	0.000104	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTEN—thyroid cancer	6.52e-06	9.04e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—thyroid cancer	6.1e-06	8.46e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—thyroid cancer	3.76e-06	5.21e-05	CbGpPWpGaD
